| # | Title | Journal | Year | Citations |
|---|
| 1 | Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis | Cancer Treatment and Research | 1996 | 1,238 |
| 2 | Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 | Nature Reviews Cancer | 2009 | 993 |
| 3 | Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial | Lancet Oncology, The | 2017 | 921 |
| 4 | Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study | Lancet Oncology, The | 2013 | 849 |
| 5 | Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study | Lancet Oncology, The | 2010 | 607 |
| 6 | Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy | Annals of Surgical Oncology | 1999 | 556 |
| 7 | A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia | American Journal of Surgical Pathology | 2016 | 528 |
| 8 | Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy | Annals of Surgery | 1995 | 509 |
| 9 | International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment | Annals of Oncology | 2011 | 407 |
| 10 | Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique | Annals of Surgical Oncology | 1999 | 364 |
| 11 | Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial | Lancet Oncology, The | 2013 | 332 |
| 12 | A Systematic Review and Meta-analysis of the Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Gastric Cancer | Annals of Surgical Oncology | 2007 | 321 |
| 13 | Successful management of microscopic residual disease in large bowel cancer | Cancer Chemotherapy and Pharmacology | 1999 | 310 |
| 14 | Systematic Review on the Efficacy of Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis From Colorectal Carcinoma | Journal of Clinical Oncology | 2006 | 308 |
| 15 | Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. | Journal of Bone and Joint Surgery - Series A | 1995 | 301 |
| 16 | A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma | Annals of Oncology | 2007 | 280 |
| 17 | A Systematic Review on the Efficacy of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei | Annals of Surgical Oncology | 2007 | 268 |
| 18 | Analysis of Prognostic Factors in Seventy Patients Having a Complete Cytoreduction plus Perioperative Intraperitoneal Chemotherapy for Carcinomatosis from Colorectal Cancer | Journal of the American College of Surgeons | 2006 | 258 |
| 19 | Cryosurgery in the Treatment of Giant Cell Tumor | Clinical Orthopaedics and Related Research | 1999 | 256 |
| 20 | Management of peritoneal-surface malignancy: the surgeon's role | Langenbeck's Archives of Surgery | 1999 | 251 |
| 21 | Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer | International Seminars in Surgical Oncology | 2005 | 248 |
| 22 | A review of peritoneal mesothelioma at the Washington Cancer Institute | Surgical Oncology Clinics of North America | 2003 | 247 |
| 23 | Prospective Morbidity and Mortality Assessment of Cytoreductive Surgery Plus Perioperative Intraperitoneal Chemotherapy To Treat Peritoneal Dissemination of Appendiceal Mucinous Malignancy | Annals of Surgical Oncology | 2006 | 240 |
| 24 | The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses | Cancer | 2000 | 219 |
| 25 | Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome | European Journal of Surgical Oncology | 2001 | 204 |
| 26 | Intraperitoneal cancer dissemination: mechanisms of the patterns of spread | Cancer and Metastasis Reviews | 2003 | 199 |
| 27 | Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2013 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group | World Journal of Emergency Surgery | 2013 | 197 |
| 28 | Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA | Annals of Oncology | 2014 | 195 |
| 29 | Distal Femur Resection With Endoprosthetic Reconstruction | Clinical Orthopaedics and Related Research | 2002 | 180 |
| 30 | Clinical presentation of the pseudomyxoma peritonei syndrome | British Journal of Surgery | 2002 | 179 |
| 31 | Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial | Lancet Oncology, The | 2012 | 168 |
| 32 | Osteosarcoma: a multidisciplinary approach to diagnosis and treatment | American Family Physician | 2002 | 168 |
| 33 | Update on Chemotherapeutic Agents Utilized for Perioperative Intraperitoneal Chemotherapy | Oncologist | 2005 | 163 |
| 34 | Thermal Enhancement of New Chemotherapeutic Agents at Moderate Hyperthermia | Annals of Surgical Oncology | 2003 | 158 |
| 35 | Pseudomyxoma peritonei syndrome | Advances in Surgery | 1996 | 155 |
| 36 | Peritonectomy procedures | Surgical Oncology Clinics of North America | 2003 | 152 |
| 37 | Update on the Surgical Approach to Mucocele of the Appendix | Journal of the American College of Surgeons | 2006 | 151 |
| 38 | Clinical Pathway for the Management of Resectable Gastric Cancer with Peritoneal Seeding: Best Palliation with a Ray of Hope for Cure | Oncology | 2000 | 150 |
| 39 | Adjuvant therapy for high‐grade, uterus‐limited leiomyosarcoma | Cancer | 2013 | 150 |
| 40 | Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy | Cancer | 2005 | 147 |
| 41 | Results of treatment of 33 patients with peritoneal mesothelioma | British Journal of Surgery | 2002 | 143 |
| 42 | Peritoneal Carcinomatosis from Adenocarcinoma of the Colon | World Journal of Surgery | 1996 | 140 |
| 43 | Intravascular Gamma Radiation for In-Stent Restenosis in Saphenous-Vein Bypass Grafts | New England Journal of Medicine | 2002 | 140 |
| 44 | Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial | Lancet Oncology, The | 2015 | 138 |
| 45 | Cardiac Tolerability of Pertuzumab Plus Trastuzumab Plus Docetaxel in Patients With HER2‐Positive Metastatic Breast Cancer in CLEOPATRA: A Randomized, Double‐Blind, Placebo‐Controlled Phase III Study | Oncologist | 2013 | 137 |
| 46 | Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology | Cancer Treatment and Research | 1996 | 137 |
| 47 | Repeat liver resections from colorectal metastasis | Surgery | 1995 | 136 |
| 48 | Epithelial Appendiceal Neoplasms | Cancer Journal (Sudbury, Mass ) | 2009 | 136 |
| 49 | Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? | Lancet Oncology, The | 2012 | 135 |
| 50 | A novel tumor‐node‐metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi‐institutional database* | Cancer | 2011 | 129 |
